Largest Drug Manufacturers - Specialty & Generic Companies by Market Cap
Largest Drug Manufacturers - Specialty & Generic companies by market cap. The Drug Manufacturers - Specialty & Generic sector has 629 publicly listed stocks with a combined market cap of $1.16 Trillion. Takeda Pharmaceutical Co Ltd ADR leads the sector with a market cap of $52.60 Billion. This ranking covers all Drug Manufacturers - Specialty & Generic stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Drug Manufacturers - Specialty & Generic Stocks by Market Capitalization (October 2026)
Top Drug Manufacturers - Specialty & Generic stocks by market capitalization as of October 2026, covering 629 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
$52.60 Billion | $52.60 Billion | USA | $16.65 | +0.30% | -6.72% | 71.71 Million |
| 2 |
GALDERMA GROUP AG
NYSE:GALDY |
$50.42 Billion | $50.42 Billion | USA | $45.98 | +2.75% | +8.91% | 1.81 Million |
| 3 |
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
$45.38 Billion | CN¥310.15 Billion | China | CN¥48.62 | +0.54% | +2.62% | 1.56 Billion |
| 4 |
Takeda Pharmaceutical Company Limited
F:TKDA |
$43.60 Billion | €37.29 Billion | Germany | €17.90 | -1.10% | +0.00% | 2.57K |
| 5 |
Haleon plc
NYSE:HLN |
$37.74 Billion | $37.74 Billion | USA | $8.57 | -14.30% | -14.47% | 451.92 Million |
| 6 |
Galderma Group N
SW:GALD |
$37.01 Billion | CHF29.28 Billion | Switzerland | CHF189.70 | +2.43% | +8.87% | 13.27 Million |
| 7 |
Zoetis Inc
NYSE:ZTS |
$34.73 Billion | $34.73 Billion | USA | $78.80 | +1.29% | -1.03% | 92.21 Million |
| 8 |
Teva Pharmaceutical Industries Limited
F:TEV |
$34.58 Billion | €29.58 Billion | Germany | €28.60 | +4.00% | +9.58% | 27.27K |
| 9 |
Sandoz Group AG
SW:SDZ |
$28.58 Billion | CHF22.61 Billion | Switzerland | CHF83.38 | +4.38% | +6.24% | 27.79 Million |
| 10 |
Merck KGaA
XETRA:MRK |
$22.71 Billion | €19.43 Billion | Germany | €150.30 | +2.91% | +5.66% | 6.34 Million |
| 11 |
HANSOH PHARMAC. HD-00001
F:3KY |
$22.06 Billion | €18.87 Billion | Germany | €3.72 | +2.48% | -3.05% | 5.03K |
| 12 |
United Therapeutics Corporation
NASDAQ:UTHR |
$21.32 Billion | $21.32 Billion | USA | $593.54 | +1.20% | +5.33% | 20.00 Million |
| 13 |
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
$18.84 Billion | Rs1.74 Trillion | India | Rs4580.00 | +0.50% | +0.58% | 7.87 Million |
| 14 |
Viatris Inc
NASDAQ:VTRS |
$18.70 Billion | $18.70 Billion | USA | $19.20 | +2.29% | +4.07% | 212.27 Million |
| 15 |
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
$18.16 Billion | Skr168.77 Billion | Sweden | Skr488.00 | +2.05% | +6.46% | 7.41 Million |
| 16 |
MERCK KGAA NAM.SP.ADR
F:MRKC |
$17.07 Billion | €14.60 Billion | Germany | €22.60 | -2.59% | -1.74% | 1.20K |
| 17 |
Yunnan Baiyao Group Co Ltd
SHE:000538 |
$13.82 Billion | CN¥94.44 Billion | China | CN¥52.93 | -0.15% | +0.25% | 219.71 Million |
| 18 |
Laurus Labs Limited
NSE:LAURUSLABS |
$13.11 Billion | Rs1.21 Trillion | India | Rs2244.00 | +2.85% | +11.50% | 39.12 Million |
| 19 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
$13.03 Billion | $13.03 Billion | USA | $146.38 | +0.58% | +3.59% | 31.17 Million |
| 20 |
IPSEN SA SP.ADR 1/4/ EO 1
F:I7G0 |
$12.92 Billion | €11.05 Billion | Germany | €40.80 | +3.03% | +0.00% | 3.43K |
| 21 |
Zydus Lifesciences Limited
NSE:ZYDUSLIFE |
$12.89 Billion | Rs1.19 Trillion | India | Rs1184.40 | +0.76% | +6.01% | 37.01 Million |
| 22 |
Cipla Limited
NSE:CIPLA |
$11.86 Billion | Rs1.10 Trillion | India | Rs1358.00 | -0.56% | +3.35% | 27.35 Million |
| 23 |
Zhejiang Nhu Co Ltd
SHE:002001 |
$11.44 Billion | CN¥78.19 Billion | China | CN¥25.44 | +0.20% | -0.74% | 443.07 Million |
| 24 |
Dr. Reddy’s Laboratories Ltd ADR
NYSE:RDY |
$11.16 Billion | $11.16 Billion | USA | $13.58 | +5.76% | +4.95% | 58.86 Million |
| 25 |
Elanco Animal Health
NYSE:ELAN |
$11.05 Billion | $11.05 Billion | USA | $23.24 | +2.60% | +3.06% | 116.86 Million |
| 26 |
Mankind Pharma Ltd
NSE:MANKIND |
$11.03 Billion | Rs1.02 Trillion | India | Rs2469.30 | -0.83% | +8.04% | 18.28 Million |
| 27 |
Ipsen SA
PA:IPN |
$10.50 Billion | €8.98 Billion | France | €155.80 | +1.90% | +2.37% | 2.78 Million |
| 28 |
Aurobindo Pharma Limited
NSE:AUROPHARMA |
$10.33 Billion | Rs955.07 Billion | India | Rs1659.90 | +0.92% | +5.14% | 19.94 Million |
| 29 |
Lupin Limited
NSE:LUPIN |
$9.84 Billion | Rs909.91 Billion | India | Rs1989.90 | +0.87% | +1.32% | 16.02 Million |
| 30 |
Krka d. d
WAR:KRK |
$9.28 Billion | zł33.73 Billion | Poland | zł1114.00 | +0.00% | -0.71% | 1.10K |
| 31 |
Dr. Reddy's Laboratories Limited
F:RDDA |
$9.23 Billion | €7.89 Billion | Germany | €12.50 | +2.46% | +6.84% | 1.40K |
| 32 |
Alkermes Plc
NASDAQ:ALKS |
$7.61 Billion | $7.61 Billion | USA | $45.37 | +0.27% | +4.35% | 47.72 Million |
| 33 |
Shanghai Fosun Pharmaceutical Group Co Ltd
SHG:600196 |
$6.92 Billion | CN¥47.26 Billion | China | CN¥22.31 | -3.04% | -3.21% | 471.63 Million |
| 34 |
H Lundbeck A/S
CO:HLUN-B |
$6.76 Billion | Dkr43.19 Billion | Denmark | Dkr54.45 | +3.13% | +9.96% | 21.21 Million |
| 35 |
Alkermes plc
F:8AK |
$6.65 Billion | €5.69 Billion | Germany | €39.31 | -0.81% | +0.18% | 0.00 |
| 36 |
Huadong Medicine Co Ltd
SHE:000963 |
$6.64 Billion | CN¥45.39 Billion | China | CN¥25.88 | -0.96% | -2.67% | 321.11 Million |
| 37 |
Alkem Laboratories Limited
NSE:ALKEM |
$6.57 Billion | Rs607.27 Billion | India | Rs5079.00 | +0.18% | +1.28% | 3.16 Million |
| 38 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
$6.56 Billion | €5.61 Billion | Germany | €35.34 | -3.23% | +2.08% | 4.35K |
| 39 |
Hims Hers Health Inc
NYSE:HIMS |
$6.55 Billion | $6.55 Billion | USA | $29.67 | +1.19% | +1.57% | 229.10 Million |
| 40 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
$6.07 Billion | CN¥41.46 Billion | China | CN¥24.91 | +0.00% | -2.47% | 264.34 Million |
| 41 |
Abbott India Limited
NSE:ABBOTINDIA |
$6.01 Billion | Rs555.56 Billion | India | Rs26145.00 | -0.49% | +1.81% | 136.78K |
| 42 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX |
$5.92 Billion | $5.92 Billion | USA | $21.35 | +0.99% | +5.69% | 94.15 Million |
| 43 |
Gland Pharma Limited
NSE:GLAND |
$5.49 Billion | Rs507.33 Billion | India | Rs3074.50 | +0.84% | +4.75% | 9.65 Million |
| 44 |
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294 |
$4.93 Billion | CN¥33.72 Billion | China | CN¥30.25 | +0.03% | -4.09% | 269.66 Million |
| 45 |
Lantheus Holdings Inc
NASDAQ:LNTH |
$4.93 Billion | $4.93 Billion | USA | $100.32 | +0.22% | +0.08% | 25.20 Million |
| 46 |
Beijing Tongrentang Co Ltd
SHG:600085 |
$4.90 Billion | CN¥33.51 Billion | China | CN¥24.43 | -1.09% | -1.69% | 162.25 Million |
| 47 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
$4.71 Billion | $4.71 Billion | USA | $97.56 | +2.50% | +22.41% | 18.74 Million |
| 48 |
Ajanta Pharma Limited
NSE:AJANTPHARM |
$4.67 Billion | Rs432.24 Billion | India | Rs3459.70 | 0.00% | +6.12% | 2.23 Million |
| 49 |
Humanwell Healthcare Group Co Ltd
SHG:600079 |
$4.65 Billion | CN¥31.75 Billion | China | CN¥19.45 | -0.56% | -0.21% | 312.10 Million |
| 50 |
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
$4.46 Billion | CN¥30.48 Billion | China | CN¥47.33 | +0.13% | +0.25% | 135.14 Million |
| 51 |
Suven Pharmaceuticals Limited
NSE:SUVENPHAR |
$4.40 Billion | Rs406.97 Billion | India | Rs1063.80 | +0.00% | +0.00% | 191.99K |
| 52 |
Changchun High & New Technology Industries Group Inc
SHE:000661 |
$4.26 Billion | CN¥29.10 Billion | China | CN¥71.33 | -0.46% | +3.15% | 111.71 Million |
| 53 |
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM |
$4.18 Billion | Rs386.77 Billion | India | Rs2408.90 | -3.87% | -1.10% | 13.52 Million |
| 54 |
Liquidia Technologies Inc
NASDAQ:LQDA |
$4.03 Billion | $4.03 Billion | USA | $44.99 | -1.60% | +15.77% | 159.10 Million |
| 55 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
$3.91 Billion | $3.91 Billion | USA | $35.25 | +1.38% | +1.32% | 55.81 Million |
| 56 |
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
$3.82 Billion | Rs353.58 Billion | India | Rs1865.00 | -0.53% | +6.26% | 2.43 Million |
| 57 |
Aspen Pharmacare Holdings Ltd
JSE:APN |
$3.76 Billion | ZAC7.07 Trillion | South Africa | ZAC15914.00 | +0.00% | +0.67% | 26.08 Million |
| 58 |
Yuhan Corp.
KO:000100 |
$3.73 Billion | ₩5.50 Trillion | Korea | ₩74700.00 | -3.36% | -13.74% | 6.92 Million |
| 59 |
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
$3.73 Billion | CN¥25.46 Billion | China | CN¥15.24 | -1.17% | -0.39% | 311.13 Million |
| 60 |
Siegfried Holding Ltd
SW:SFZN |
$3.71 Billion | CHF2.94 Billion | Switzerland | CHF70.80 | -2.07% | -1.12% | 2.38 Million |
| 61 |
Laboratorios Farmaceuticos ROVI
MC:ROVI |
$3.68 Billion | €3.15 Billion | Spain | €61.55 | +0.41% | +4.59% | 2.22 Million |
| 62 |
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
$3.63 Billion | CN¥24.77 Billion | China | CN¥26.88 | +0.64% | +2.32% | 155.61 Million |
| 63 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
$3.57 Billion | $3.57 Billion | USA | $12.18 | +2.01% | -2.72% | 43.40 Million |
| 64 |
INDIVIOR PLC DL 050
F:2IVB |
$3.51 Billion | €3.01 Billion | Germany | €27.00 | -1.53% | -0.74% | 1.51K |
| 65 |
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
$3.48 Billion | CN¥23.81 Billion | China | CN¥15.90 | -1.85% | -4.45% | 728.16 Million |
| 66 |
Wockhardt Limited
NSE:WOCKPHARMA |
$3.38 Billion | Rs312.46 Billion | India | Rs1922.90 | +0.50% | +2.43% | 16.37 Million |
| 67 |
Hanmi Pharm Co Ltd
KO:128940 |
$3.34 Billion | ₩4.93 Trillion | Korea | ₩388500.00 | +5.14% | +2.37% | 2.54 Million |
| 68 |
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
$3.34 Billion | CN¥22.79 Billion | China | CN¥39.98 | -1.26% | -3.01% | 101.68 Million |
| 69 |
Piramal Pharma Limited
NSE:PPLPHARMA |
$3.31 Billion | Rs305.79 Billion | India | Rs230.78 | -0.87% | +20.71% | 198.62 Million |
| 70 |
Apeloa Pharmaceutical Co Ltd
SHE:000739 |
$3.31 Billion | CN¥22.59 Billion | China | CN¥19.50 | -3.47% | -7.93% | 430.51 Million |
| 71 |
Bausch Health Companies Inc
TO:BHC |
$3.30 Billion | CA$4.57 Billion | Canada | CA$12.41 | +28.34% | +36.98% | 13.89 Million |
| 72 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
$3.20 Billion | $3.20 Billion | USA | $28.68 | +2.17% | -1.21% | 31.06 Million |
| 73 |
SIMCERE PHARMAC. GRP LTD
F:S2P |
$3.17 Billion | €2.72 Billion | Germany | €1.18 | +0.85% | -3.28% | 0.00 |
| 74 |
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
$3.14 Billion | CN¥21.47 Billion | China | CN¥21.20 | -0.61% | -3.20% | 179.09 Million |
| 75 |
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
$2.98 Billion | CN¥20.33 Billion | China | CN¥13.61 | -0.51% | -2.16% | 299.66 Million |
| 76 |
Hypera S.A
SA:HYPE3 |
$2.97 Billion | R$15.15 Billion | Brazil | R$21.52 | -1.01% | -17.83% | 118.81 Million |
| 77 |
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU |
$2.95 Billion | €2.52 Billion | Germany | €6.90 | +4.55% | +0.73% | 240.00 |
| 78 |
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
$2.94 Billion | CN¥20.08 Billion | China | CN¥23.63 | -0.55% | -11.80% | 701.30 Million |
| 79 |
Hybio Pharmaceutical
SHE:300199 |
$2.88 Billion | CN¥19.71 Billion | China | CN¥22.31 | -3.67% | -16.47% | 1.26 Billion |
| 80 |
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623 |
$2.87 Billion | CN¥19.60 Billion | China | CN¥16.39 | -1.97% | -3.70% | 183.05 Million |
| 81 |
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
$2.72 Billion | $2.72 Billion | USA | $6.86 | -5.64% | -36.48% | 8.94 Million |
| 82 |
Walvax BioTech
SHE:300142 |
$2.69 Billion | CN¥18.41 Billion | China | CN¥11.51 | -5.42% | -11.05% | 1.80 Billion |
| 83 |
Neuland Laboratories Limited
NSE:NEULANDLAB |
$2.68 Billion | Rs247.36 Billion | India | Rs19280.00 | -3.46% | +1.61% | 1.11 Million |
| 84 |
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380 |
$2.66 Billion | CN¥18.20 Billion | China | CN¥9.95 | +0.10% | +6.65% | 483.90 Million |
| 85 |
Almirall S.A.
MC:ALM |
$2.63 Billion | €2.25 Billion | Spain | €10.52 | +0.96% | +1.35% | 2.56 Million |
| 86 |
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
$2.58 Billion | CN¥17.63 Billion | China | CN¥83.12 | -0.30% | -3.19% | 124.70 Million |
| 87 |
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
$2.55 Billion | CN¥17.42 Billion | China | CN¥1.26 | +0.00% | -2.33% | 2.87 Billion |
| 88 |
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
$2.55 Billion | CN¥17.41 Billion | China | CN¥18.90 | -0.21% | -5.17% | 182.15 Million |
| 89 |
Curaleaf Holdings Inc.
TO:CURA |
$2.52 Billion | CA$3.49 Billion | Canada | CA$12.13 | +1.85% | +6.59% | 7.03 Million |
| 90 |
Betta Pharmaceuticals Co Ltd
SHE:300558 |
$2.47 Billion | CN¥16.85 Billion | China | CN¥40.04 | -2.03% | -4.78% | 245.00 Million |
| 91 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
$2.43 Billion | $2.43 Billion | USA | $41.84 | +1.85% | +1.53% | 22.32 Million |
| 92 |
Livzon Pharmaceutical Group Inc
SHE:000513 |
$2.38 Billion | CN¥16.26 Billion | China | CN¥27.64 | -0.68% | +2.52% | 351.31 Million |
| 93 |
Prestige Brand Holdings Inc
NYSE:PBH |
$2.31 Billion | $2.31 Billion | USA | $48.75 | +2.01% | +1.73% | 13.06 Million |
| 94 |
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
$2.31 Billion | CN¥15.76 Billion | China | CN¥15.17 | -2.32% | -5.83% | 184.25 Million |
| 95 |
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
$2.25 Billion | CN¥15.39 Billion | China | CN¥14.59 | -0.34% | -1.55% | 97.98 Million |
| 96 |
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
$2.23 Billion | CN¥15.25 Billion | China | CN¥12.72 | -5.07% | -8.82% | 889.35 Million |
| 97 |
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
$2.23 Billion | CN¥15.24 Billion | China | CN¥7.78 | +2.64% | -0.13% | 343.19 Million |
| 98 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
$2.17 Billion | $2.17 Billion | USA | $8.52 | +1.79% | +9.94% | 130.05 Million |
| 99 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
$2.12 Billion | $2.12 Billion | USA | $21.64 | +0.05% | +0.28% | 72.66 Million |
| 100 |
Jiangzhong Pharmaceutical Co Ltd
SHG:600750 |
$2.05 Billion | CN¥14.03 Billion | China | CN¥22.08 | +0.59% | -4.54% | 114.59 Million |
| 101 |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766 |
$2.02 Billion | CN¥13.82 Billion | China | CN¥14.30 | -3.38% | -6.84% | 266.43 Million |
| 102 |
Perrigo Company PLC
NYSE:PRGO |
$2.01 Billion | $2.01 Billion | USA | $15.90 | -0.13% | -0.06% | 57.94 Million |
| 103 |
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601 |
$2.00 Billion | CN¥13.64 Billion | China | CN¥12.21 | -2.55% | -2.16% | 411.55 Million |
| 104 |
Shilpa Medicare Limited
NSE:SHILPAMED |
$1.98 Billion | Rs182.99 Billion | India | Rs935.60 | +0.39% | +10.70% | 20.13 Million |
| 105 |
Dermapharm Holding SE
XETRA:DMP |
$1.97 Billion | €1.68 Billion | Germany | €38.55 | +0.92% | -0.64% | 427.93K |
| 106 |
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
$1.95 Billion | CN¥13.32 Billion | China | CN¥5.29 | -2.94% | -11.39% | 8.08 Billion |
| 107 |
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
$1.94 Billion | CN¥13.27 Billion | China | CN¥15.05 | -2.15% | -10.36% | 530.65 Million |
| 108 |
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SHG:603707 |
$1.89 Billion | CN¥12.91 Billion | China | CN¥7.99 | -1.11% | -1.84% | 246.98 Million |
| 109 |
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
$1.87 Billion | CN¥12.79 Billion | China | CN¥28.32 | -2.75% | -8.23% | 91.16 Million |
| 110 |
HUTCHMED (China) Limited
F:H7T1 |
$1.84 Billion | €1.57 Billion | Germany | €11.80 | -1.67% | -7.81% | 0.00 |
| 111 |
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
$1.80 Billion | CN¥12.27 Billion | China | CN¥73.05 | -1.28% | -8.57% | 74.06 Million |
| 112 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
$1.76 Billion | $1.76 Billion | USA | $15.50 | +0.00% | +0.10% | 76.22 Million |
| 113 |
Porton Fine Chemicals Ltd
SHE:300363 |
$1.75 Billion | CN¥11.93 Billion | China | CN¥21.95 | -1.35% | +0.97% | 398.48 Million |
| 114 |
Eris Lifesciences Limited
NSE:ERIS |
$1.74 Billion | Rs161.26 Billion | India | Rs1163.60 | -1.00% | +2.40% | 3.81 Million |
| 115 |
Alembic Pharmaceuticals Limited
NSE:APLLTD |
$1.69 Billion | Rs156.24 Billion | India | Rs794.85 | +1.54% | +0.88% | 4.13 Million |
| 116 |
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
$1.68 Billion | CN¥11.51 Billion | China | CN¥35.71 | -0.78% | -2.06% | 54.76 Million |
| 117 |
Guobang Pharma Ltd
SHG:605507 |
$1.66 Billion | CN¥11.34 Billion | China | CN¥14.50 | -2.09% | -6.27% | 182.70 Million |
| 118 |
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285 |
$1.66 Billion | CN¥11.34 Billion | China | CN¥20.00 | +0.05% | -3.15% | 207.37 Million |
| 119 |
Shenzhen Hepalink Pharmaceutical Co Ltd
SHE:002399 |
$1.66 Billion | CN¥11.32 Billion | China | CN¥9.08 | -1.41% | -2.68% | 77.45 Million |
| 120 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
$1.64 Billion | $1.64 Billion | USA | $73.16 | +2.02% | +1.27% | 7.89 Million |
| 121 |
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
$1.62 Billion | Rs149.83 Billion | India | Rs946.00 | +0.22% | +1.79% | 6.66 Million |
| 122 |
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
$1.60 Billion | CN¥10.94 Billion | China | CN¥11.79 | -3.68% | -5.15% | 353.80 Million |
| 123 |
Shanghai Shyndec Pharmaceutical Co Ltd
SHG:600420 |
$1.58 Billion | CN¥10.81 Billion | China | CN¥8.06 | -0.25% | -1.95% | 156.94 Million |
| 124 |
BORA PHARMACEUTICALS LTD
TW:6472 |
$1.57 Billion | NT$49.90 Billion | Taiwan | NT$392.00 | -1.01% | -5.08% | 11.55 Million |
| 125 |
Fagron NV
BR:FAGR |
$1.55 Billion | €1.33 Billion | Belgium | €23.40 | -1.89% | -0.43% | 2.88 Million |
| 126 |
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572 |
$1.55 Billion | CN¥10.59 Billion | China | CN¥4.17 | +0.24% | -2.80% | 988.78 Million |
| 127 |
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675 |
$1.54 Billion | CN¥10.54 Billion | China | CN¥12.78 | -0.78% | -2.37% | 282.96 Million |
| 128 |
H Lundbeck A/S
CO:HLUN-A |
$1.54 Billion | Dkr9.82 Billion | Denmark | Dkr49.35 | +1.65% | +5.34% | 1.43 Million |
| 129 |
Eton Pharmaceuticals Inc
NASDAQ:ETON |
$1.53 Billion | $1.53 Billion | USA | $53.67 | +3.61% | +8.86% | 12.84 Million |
| 130 |
Natco Pharma Limited
NSE:NATCOPHARM |
$1.53 Billion | Rs141.06 Billion | India | Rs787.55 | -0.69% | +0.40% | 11.67 Million |
| 131 |
Mayinglong Pharmaceutical Group Co Ltd
SHG:600993 |
$1.52 Billion | CN¥10.37 Billion | China | CN¥24.05 | +0.21% | +1.35% | 134.79 Million |
| 132 |
Zhejiang Medicine Co Ltd
SHG:600216 |
$1.49 Billion | CN¥10.20 Billion | China | CN¥10.61 | -2.66% | -12.17% | 301.00 Million |
| 133 |
PharmaBlock Sciences Nanjing Inc Class A
SHE:300725 |
$1.46 Billion | CN¥9.98 Billion | China | CN¥42.70 | -2.82% | -5.66% | 489.23 Million |
| 134 |
Lotus Pharmaceutical Co Ltd
TW:1795 |
$1.45 Billion | NT$45.90 Billion | Taiwan | NT$172.50 | -0.86% | -1.43% | 16.79 Million |
| 135 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
$1.40 Billion | $1.40 Billion | USA | $10.75 | +1.03% | -0.32% | 76.24 Million |
| 136 |
Faes Farma SA
MC:FAE |
$1.40 Billion | €1.19 Billion | Spain | €4.78 | +0.74% | +0.74% | 4.32 Million |
| 137 |
Zhejiang Jingxin Pharmaceutical Co Ltd
SHE:002020 |
$1.39 Billion | CN¥9.52 Billion | China | CN¥11.06 | -0.09% | -3.49% | 282.73 Million |
| 138 |
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263 |
$1.38 Billion | CN¥9.45 Billion | China | CN¥18.50 | -0.43% | +0.65% | 110.12 Million |
| 139 |
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099 |
$1.37 Billion | CN¥9.39 Billion | China | CN¥5.80 | -0.17% | -1.36% | 567.30 Million |
| 140 |
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
$1.35 Billion | CN¥9.25 Billion | China | CN¥3.08 | -0.65% | -2.22% | 931.93 Million |
| 141 |
CONSUN PHARMAC.GR.HD -10
F:C1P |
$1.35 Billion | €1.15 Billion | Germany | €1.67 | -2.91% | -4.57% | 0.00 |
| 142 |
Cronos Group Inc
TO:CRON |
$1.31 Billion | CA$1.81 Billion | Canada | CA$4.73 | +0.42% | -0.21% | 2.18 Million |
| 143 |
Hanall Biopharma
KO:009420 |
$1.30 Billion | ₩1.92 Trillion | Korea | ₩37800.00 | -1.82% | -8.70% | 5.02 Million |
| 144 |
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
$1.28 Billion | CN¥8.76 Billion | China | CN¥8.86 | -0.45% | +1.03% | 345.83 Million |
| 145 |
Perrigo Company plc
F:PIG |
$1.28 Billion | €1.10 Billion | Germany | €14.25 | +0.78% | +1.89% | 2.33K |
| 146 |
Teva Pharmaceutical Industries Ltd
TA:TEVA |
$1.28 Billion | ILA475.95 Billion | Israel | ILA12720.00 | +0.87% | -1.62% | 25.52 Million |
| 147 |
BioGaia AB (publ)
ST:BIOG-B |
$1.27 Billion | Skr11.81 Billion | Sweden | Skr119.90 | -1.24% | -3.31% | 4.58 Million |
| 148 |
Wedge Industrial Co Ltd
SHE:000534 |
$1.24 Billion | CN¥8.49 Billion | China | CN¥16.66 | -2.91% | -14.39% | 301.01 Million |
| 149 |
Cansino Biologics Inc
SHG:688185 |
$1.24 Billion | CN¥8.44 Billion | China | CN¥73.80 | -5.74% | -7.37% | 259.10 Million |
| 150 |
Akums Drugs and Pharmaceutical
NSE:AKUMS |
$1.23 Billion | Rs113.46 Billion | India | Rs741.05 | +2.54% | +6.77% | 4.84 Million |
How Drug Manufacturers - Specialty & Generic Companies Are Ranked by Market Cap
Drug Manufacturers - Specialty & Generic companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Drug Manufacturers - Specialty & Generic industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - specialty & generic corporations. View all industries